Resources

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (September 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

Presentations from the 2019 MS Summit

View Presentations here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (June 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (April 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

MS Coalition Brochure (January 2012)

The Multiple Sclerosis Coalition (MSC) was founded in 2005 by three independent multiple sclerosis (MS) organizations in an effort to work together to benefit individuals with MS. Since that time, the MSC has grown to nine member organizations, all of whom provide critical MS programs and services.    Download here

Follow us on Twitter

TwitterFollow

MS Coalition
Retweet on TwitterMS Coalition Retweeted
UnitedSpinalUnited Spinal@UnitedSpinal·
16h

United Spinal Association is thankful for the @FCC’s leadership in establishing "988" as a three-digit code for the national suicide prevention and mental health crisis hotline. (1/3)

https://www.usatoday.com/story/news/nation/2019/12/12/988-suicide-prevention-number-fcc-approval/4411812002/

Reply on Twitter 1282743455849029632Retweet on Twitter 12827434558490296323Like on Twitter 12827434558490296326Twitter 1282743455849029632
Retweet on TwitterMS Coalition Retweeted
MS_FocusMS Focus: The Multiple Sclerosis Foundation@MS_Focus·
10 Jul

Cathy, a dedicated MS advocate, was diagnosed with Relapsing-Remitting Multiple Sclerosis at 27 years old. She says, “MS has taught me to respect the fragility of life and how important it is to be mindful of every moment. You never know what tomorrow will bring."

Reply on Twitter 1281573922169917441Retweet on Twitter 12815739221699174414Like on Twitter 128157392216991744116Twitter 1281573922169917441
Retweet on TwitterMS Coalition Retweeted
CanDoMSCan Do MS@CanDoMS·
7 Jul

Join us LIVE (Tuesday, July 14) for a webinar on how #MS can affect vision and sensation. Register today to explore management strategies and treatment options!

https://www.cando-ms.org/multiple-sclerosis-programs/webinar-series

Reply on Twitter 1280614828088782849Retweet on Twitter 12806148280887828492Like on Twitter 12806148280887828494Twitter 1280614828088782849
Load More...